DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

42.50 -0.31 (-0.72%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $42.50 -0.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.00
Previous Close $42.81
Daily Range $42.20 - $43.14
52-Week Range $30.05 - $44.95
Market Cap $5.3B
P/E Ratio -64.86
Dividend (Yield) $0.00 (0.0%)
Volume 1,276,429
Average Daily Volume 1,200,403
Current FY EPS -$0.76




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

4 Big Biotech Companies to Sell Now

Otonomy, Renren And Other Names To Watch Heading Into Next Week

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

See More SGEN News...

SGEN's Top Competitors

SGEN $42.50 (-0.72%)
Current stock: SGEN
AMGN $160.44 (0.90%)
Current stock: AMGN
GILD $112.46 (2.45%)
Current stock: GILD
BIIB $402.92 (2.56%)
Current stock: BIIB